Market research
2191.TSE tella, Inc
TSE JPY Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 51M
- P/E ratio
- Not available
- Analyst target
- 490
- Dividend yield
- 0.0%
- Beta
- 1.85
Profile
Company facts
- Exchange
- TSE
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Life Sciences Tools & Services
- ISIN
- JP3545900007
- Market cap
- 51M
- P/E ratio
- Not available
- Analyst target
- 490
- Dividend yield
- 0.0%
- Beta
- 1.85
About
About tella, Inc
tella, Inc. researches and develops regenerative and cell medicines. The company offers techniques and operational knowhow associated with dendritic cell vaccine therapy to affiliated medical institutions for the treatment of cancer. It is also involved in the provision of consultation services on the establishment and maintenance of cell processing centers, and on introduction of management systems for cell cultivation; and lease of standard operating procedure and regular checks on manufacturing operation management and training of cell cultivation technicians. In addition, the company provides consultation services on training of expertise regarding treatment practice; and support services for the assessment of therapies, documentation required for treatment practice, and cognition and information providing activities for physicians and patients. tella, Inc. was founded in 2004 and is based in Tokyo, Japan.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the 2191.TSE discussion.
5 years, 5 months ago
tella, Inc is currently in a long term downtrend where the price is trading 41.5% below its 200 day moving average.
From a valuation standpoint, the stock is 0.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 70.3.
tella, Inc's total revenue sank by 1.8% to $27M since the same quarter in the previous year.
Its net income has increased by 95.6% to $-10M since the same quarter in the previous year.
Based on the above factors, tella, Inc gets an overall score of 2/5.